Home › Diffuse Large B-Cell Lymphoma › Wisconsin › Milwaukee
Diffuse Large B-Cell Lymphoma clinical trials in Milwaukee, WI
16 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in and around Milwaukee (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
RecruitingPhase 2
- Medical College of Wisconsin ( Site 0103), Milwaukee
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
RecruitingPhase 2
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11 mi away
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 mi away
- and 3 more
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecruitingPhase 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RecruitingPhase 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of ARC-02 in B-cell NHL
RecruitingPhase 1
- Froedtert & Medical College of Wisconsin, Milwaukee
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- Medical College of Wisconsin, Milwaukee
Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma
RecruitingPhase 2
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
RecruitingPhase 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
RecruitingObservational study
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
DALY II USA/ MB-CART2019.1 for DLBCL
RecruitingPhase 2
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- Medical College of Wisconsin, Milwaukee
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RecruitingObservational study
- Children's Hospital of Wisconsin, Milwaukee
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
RecruitingPhase 1/2
- Medical College of Wisconsin and Froedtert Hospital, Milwaukee
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
RecruitingPhase 2
- Medical College of Wisconsin, Milwaukee
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 mi away
Long-term Follow-up Study of Patients Receiving CAR-T Cells
RecruitingObservational study
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
RecruitingPhase 2
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- and 4 more
Diffuse Large B-Cell Lymphoma trials in other cities
- New York City, NY21 studies
- Baldwin Park, CA19 studies
- Chicago, IL18 studies
- Los Angeles, CA17 studies
- Houston, TX17 studies
- Boston, MA16 studies
- Philadelphia, PA15 studies
- Portland, OR15 studies
- Nashville, TN14 studies
- Durham, NC14 studies
- Dallas, TX13 studies
- Washington, DC12 studies
Other studies in Milwaukee
- Breast Cancer24 studies
- Cancer (all types)23 studies
- Non-Small Cell Lung Cancer22 studies
- Multiple Myeloma21 studies
- Lung Cancer21 studies
- Prostate Cancer20 studies
- Follicular Lymphoma19 studies
- Pancreatic Cancer18 studies
- Non-Hodgkin Lymphoma18 studies
- Acute Myeloid Leukemia17 studies
- Ovarian Cancer17 studies
- Heart Failure16 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.